CYP71B34 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to CYP71B34 Antibody

The CYP71B34 Antibody is a specific tool used to detect the cytochrome P450 enzyme CYP71B34, which belongs to the family 71, subfamily B, polypeptide 34 in Arabidopsis thaliana. This enzyme is part of a large family of cytochrome P450 enzymes that play crucial roles in plant metabolism, including the synthesis and modification of various compounds such as phenylpropanoids, alkaloids, and terpenoids.

What is CYP71B34?

CYP71B34 is a putative cytochrome P450 enzyme identified in Arabidopsis thaliana with the gene identifier AT3G26300 . Cytochrome P450 enzymes are known for their involvement in a wide range of biochemical reactions, including hydroxylation, epoxidation, and reduction. These enzymes are integral to plant defense mechanisms, hormone biosynthesis, and the metabolism of xenobiotics.

Role of CYP71B34 Antibody

The CYP71B34 Antibody is used in research to study the expression and localization of the CYP71B34 enzyme in plant tissues. This antibody can be employed in various immunological techniques such as Western blotting, immunofluorescence, and immunohistochemistry to detect the presence of CYP71B34 in different plant samples.

Table 1: Techniques for Using CYP71B34 Antibody

TechniqueDescriptionApplication
Western BlottingDetection of proteins separated by gel electrophoresisAnalyzing protein expression levels
ImmunofluorescenceVisualization of proteins in intact cellsStudying protein localization
ImmunohistochemistryDetection of proteins in tissue sectionsExamining protein distribution in tissues

Table 2: Potential Applications of CYP71B34 Antibody

ApplicationDescription
Plant Metabolism StudiesInvestigating the role of CYP71B34 in plant metabolic pathways
BiotechnologyDeveloping genetically modified plants with altered metabolic profiles
Environmental ScienceStudying plant responses to environmental stressors

Challenges and Future Directions

Producing antibodies in plants, such as Arabidopsis thaliana, can be challenging due to differences in post-translational modifications compared to mammalian systems . Future research should focus on optimizing antibody production in plants and exploring the full potential of CYP71B34 in plant biology.

References ThaleMine. Gene CYP71B34 A. thaliana. High-throughput screening of monoclonal antibodies against plant cell wall glycans. A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis. Western blotting guide: Part 6, Secondary Antibodies. Comparison of CD20 Binding Affinities of Rituximab Produced in Different Hosts. Laboratory of Translational Immunology. Anti-Tubulin alpha chain (polyclonal antibodies). NIMIN1 / Anti-Protein NIM1-INTERACTING 1 Antibody. Targeting CD47: the achievements and concerns of current studies on cancer immunotherapy. Complete humanization of the mouse immunoglobulin loci enables production of fully human antibodies.

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
CYP71B34 antibody; At3g26300 antibody; F20C19.2Cytochrome P450 71B34 antibody; EC 1.14.-.- antibody
Target Names
CYP71B34
Uniprot No.

Target Background

Database Links

KEGG: ath:AT3G26300

STRING: 3702.AT3G26300.1

UniGene: At.28179

Protein Families
Cytochrome P450 family
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

Basic Research Questions

  • What is CYP71B34 and what are the challenges in generating antibodies against it?
    CYP71B34 (Cytochrome P450 71B34) is a membrane-associated enzyme in Arabidopsis thaliana with currently unassigned function . As a plant cytochrome P450, it likely plays a role in specialized metabolism pathways.
    Generating antibodies against CYP71B34 presents several challenges:

    • It is typically expressed at low abundance in plant tissues

    • Being a membrane protein makes purification difficult

    • It may share sequence homology with other CYP family members

    • Plant proteins often have extensive post-translational modifications
      These factors make conventional immunization approaches time-consuming and potentially ineffective. Alternative strategies like genetic immunization may be more suitable for generating specific antibodies .

  • Which experimental methods are most effective for validating CYP71B34 antibody specificity?
    Validating antibody specificity is crucial for reliable research. For CYP71B34 antibodies, consider:

    Validation MethodTechnical ApproachControls Needed
    Western blottingCompare wild-type vs. knockout plant extractsWild-type, CYP71B34 knockout, blocking peptide
    ImmunoprecipitationPull-down and mass spectrometry confirmationIgG isotype control
    Overexpression validationTest against tissues overexpressing the targetEmpty vector control
    Peptide competitionPre-incubate antibody with immunizing peptideNon-competing peptide control
    For comprehensive validation, use microsomal fractions from wild-type Arabidopsis leaves compared against plants with altered CYP71B34 expression . If the antibody is specific, it should recognize a single protein band in wild-type samples that is absent or altered in knockout/knockdown lines.
  • What are effective extraction protocols for detecting CYP71B34 in plant tissues?
    To effectively isolate CYP71B34 from plant tissues for antibody detection:

    1. Use membrane-protein specific extraction buffers containing:

      • 20 mM MES buffer (pH 6.8)

      • 250 mM sucrose

      • 1 mM EDTA

      • 1 mM DTT

      • Protease inhibitor cocktail

    2. Perform differential centrifugation steps:

      • Low-speed centrifugation (1,000g for 10 min) to remove debris

      • Medium-speed centrifugation (10,000g for 15 min) for organelles

      • High-speed ultracentrifugation (100,000g for 1 hour) to collect microsomal fractions

    3. For RNA extraction to assess gene expression alongside protein levels:

      • Use CTAB buffer-based extraction protocol for semi-russeted varieties

      • Alternatively, use commercial kits like RNeasy plant mini kit with on-column DNase I treatment
        Keep all samples at 4°C during extraction to minimize protein degradation. The microsomal fraction is typically where membrane-bound CYP enzymes concentrate.

  • How can I determine appropriate antibody dilutions for different applications?
    Optimizing antibody dilutions is essential for maximizing signal-to-noise ratio. For CYP71B34 antibodies:

    ApplicationRecommended Starting Dilution RangeOptimization Strategy
    Western blot1:500 to 1:2,000Serial dilution series
    Immunohistochemistry1:100 to 1:500Tissue-specific titration
    ELISA1:1,000 to 1:5,000Checkerboard titration
    Immunofluorescence1:200 to 1:1,000Signal-to-background assessment
    When testing a new CYP71B34 antibody, begin with a multiple-point dilution series and assess signal strength and background levels. For Western blots, consider dot blots with purified protein (if available) as a quick preliminary test .
    For polyclonal antibodies, testing across different bleeds is recommended as antibody titers can vary significantly between production batches.

Advanced Research Questions

  • What are the comparative advantages of genetic immunization versus traditional methods for generating CYP71B34 antibodies?
    Genetic immunization offers several advantages for generating antibodies against plant membrane proteins like CYP71B34:

    ParameterGenetic ImmunizationTraditional Protein Immunization
    Antigen preparationDNA encoding target proteinPurified protein or synthesized peptide
    Time requirement8-12 weeks12-16 weeks (including protein purification)
    Native conformationPreserved (in vivo expression)Often compromised during purification
    Post-translational modificationsMaintained when expressed in animal cellsUsually absent in recombinant/synthetic antigens
    Success with membrane proteinsHigher (70-80%)Lower (30-40%)
    Cost effectivenessHigherLower (requires protein purification)
    Research has demonstrated that genetic immunization can successfully generate antibodies against low-abundance plant membrane proteins without requiring the labor-intensive purification of native or recombinant proteins . The method involves direct injection of plasmid DNA encoding CYP71B34 into animals, allowing in vivo expression of the protein with proper folding and post-translational modifications.
    In one study, genetic immunization successfully produced monoclonal antibodies against KAT1, a low-abundance plant plasma membrane potassium channel, with high specificity - recognizing a single protein band in microsomal fractions . This approach would be particularly valuable for CYP71B34, which similarly represents a low-abundance membrane protein.
  • How can I address cross-reactivity issues between CYP71B34 and closely related CYP71 family members?
    Cross-reactivity is a significant challenge when working with cytochrome P450 antibodies due to sequence homology. To address this:

    1. Epitope Selection Strategy:

      • Target unique regions in CYP71B34 that differ from close family members (especially CYP71B35)

      • Avoid highly conserved substrate recognition sites and heme-binding domains

      • Perform multiple sequence alignment of the CYP71 family to identify divergent regions

    2. Absorption Controls:

      • Pre-absorb antibodies with recombinant proteins/peptides from related CYP71 family members

      • Create a testing panel of closely related CYP proteins to assess cross-reactivity

    3. Validation in Multiple Systems:

      • Test antibody specificity in:

        • Wild-type plants

        • CYP71B34 knockout/knockdown plants

        • Heterologous expression systems overexpressing CYP71B34

        • Systems expressing related CYP71 family members

    4. Advanced Purification Techniques:

      • Perform affinity purification against the specific immunogen

      • Consider negative selection against related family members
        Recent advances in antibody design suggest implementing machine learning algorithms for computational mutagenesis of CDR3 regions to optimize antibody specificity for CYP71B34 . This approach could help design antibodies with enhanced discrimination between closely related CYP family members.

  • What are effective strategies for using CYP71B34 antibodies in co-immunoprecipitation studies to identify interaction partners?
    Co-immunoprecipitation (Co-IP) with CYP71B34 antibodies requires specialized approaches due to its membrane localization:

    1. Membrane Solubilization Protocol:

      • Use mild detergents to solubilize membrane proteins while preserving protein-protein interactions:

        • 1% Digitonin

        • 0.5-1% CHAPS

        • 0.5-1% NP-40 or Triton X-100

      • Test multiple detergent conditions to optimize solubilization efficiency vs. preservation of interactions

    2. Co-IP Workflow Optimization:

      • Cross-linking step (optional): Use membrane-permeable crosslinkers (DSP, formaldehyde) to stabilize transient interactions

      • Pre-clearing with Protein A/G: Remove non-specific binding proteins

      • Antibody incubation: Use 2-5 μg antibody per 500 μg protein lysate

      • Bead selection: Magnetic beads offer gentler handling for membrane protein complexes

      • Elution strategy: Consider native elution with excess antigen peptide

    3. Controls for Co-IP Validation:

      • Input control (5-10% of starting material)

      • IgG isotype control

      • Reverse Co-IP when possible (IP with antibody against suspected interaction partner)

      • Knockout/knockdown validation

      • Competition with immunizing peptide

    4. Downstream Analysis Options:

      • Western blot for suspected interaction partners

      • Mass spectrometry for unbiased identification

      • Functional validation through mutagenesis of interaction domains
        This approach has been successful in identifying protein-protein interactions in plant signaling networks, such as those involving the BSL family proteins in Solanum tuberosum, which could serve as a methodological model .

  • How can CYP71B34 antibodies be used to investigate enzyme localization and trafficking in plant cells?
    CYP71B34 antibodies can be powerful tools for subcellular localization studies using these approaches:

    1. Immunofluorescence Microscopy Protocol:

      • Tissue fixation: 4% paraformaldehyde in PBS (pH 7.4)

      • Permeabilization: 0.1-0.5% Triton X-100 for 10-30 minutes

      • Blocking: 2-5% BSA or normal serum for 1 hour

      • Primary antibody: Anti-CYP71B34 (1:200-1:500) overnight at 4°C

      • Secondary antibody: Fluorophore-conjugated anti-species IgG (1:500-1:1000)

      • Counterstains: DAPI for nuclei, organelle-specific markers

      • Mounting: Anti-fade medium to prevent photobleaching

    2. Subcellular Fractionation and Western Blot:

      • Differential centrifugation to isolate:

        • Plasma membrane

        • Endoplasmic reticulum

        • Golgi apparatus

        • Tonoplast

      • Marker proteins for fraction validation:

        • H⁺-ATPase (plasma membrane)

        • BiP (endoplasmic reticulum)

        • TGN46 (Golgi)

      • Western blot analysis with CYP71B34 antibodies to determine distribution

    3. Immuno-Electron Microscopy:

      • Ultra-thin sectioning (70-90 nm)

      • Immunogold labeling with CYP71B34 antibodies

      • Quantitative analysis of gold particle distribution

    4. Live Cell Imaging (Indirect):

      • Generate fusion proteins (CYP71B34-fluorescent protein)

      • Validate localization pattern matches antibody staining

      • Use for dynamic trafficking studies
        These approaches can be combined to build a comprehensive understanding of CYP71B34's subcellular localization and potential relocalization under different conditions or developmental stages.

  • What techniques can be used to quantify CYP71B34 protein levels in response to environmental stresses or chemical treatments?
    Quantifying CYP71B34 protein levels requires sensitive and specific detection methods:

    1. Quantitative Western Blot Analysis:

      • Sample preparation: Microsomal fractions from treated vs. control plants

      • Loading normalization: Equal protein loading (verified by BCA/Bradford assay)

      • Internal controls: Constitutively expressed membrane proteins

      • Detection: Chemiluminescence or fluorescence-based detection

      • Quantification: Densitometry with standard curve of recombinant protein

    2. ELISA-Based Quantification:

      • Direct ELISA: Coat wells with total protein extract

      • Sandwich ELISA: Capture antibody against CYP71B34, detection with tagged secondary antibody

      • Standard curve: Recombinant CYP71B34 protein (if available)

    3. Parallel Gene Expression Analysis:

      • RNA extraction using CTAB buffer-based protocols or commercial kits

      • RT-qPCR for CYP71B34 transcript levels using gene-specific primers

      • Reference genes: Use multiple stable reference genes like ACT2, UBQ10, EF1α

    4. Experimental Design Considerations:

      • Time-course sampling: Capture early and late responses

      • Concentration gradients: Test multiple treatment levels

      • Tissue specificity: Analyze different plant tissues separately

      • Biological replicates: Minimum 3-4 independent experiments
        Research on TCE-induced hepatitis has shown that cytochrome P450 enzymes (specifically CYP2E1) can be quantified through autoantibody measurements, suggesting potential methodological parallels for plant CYP studies .

  • How can I design experiments to investigate potential post-translational modifications of CYP71B34 using antibodies?
    Investigating post-translational modifications (PTMs) of CYP71B34 requires specialized experimental approaches:

    1. PTM-Specific Antibody Approaches:

      • Phosphorylation detection:

        • Use phospho-specific antibodies if available

        • Alternative: Immunoprecipitate with anti-CYP71B34, then blot with anti-phospho-Ser/Thr/Tyr

      • Glycosylation analysis:

        • Enzymatic deglycosylation (PNGase F, Endo H) followed by Western blot to detect mobility shifts

        • Lectin blotting after CYP71B34 immunoprecipitation

      • Ubiquitination/SUMOylation:

        • Immunoprecipitate under denaturing conditions

        • Blot with anti-ubiquitin or anti-SUMO antibodies

    2. Mass Spectrometry Workflow:

      • Immunoprecipitate CYP71B34 from plant extracts

      • In-gel or in-solution digestion with trypsin

      • Enrichment strategies for specific PTMs:

        • TiO₂ for phosphopeptides

        • IMAC for phosphopeptides

        • Lectin affinity for glycopeptides

      • LC-MS/MS analysis with PTM-specific detection parameters

      • Database searching with variable modifications

    3. In Vitro Modification Assays:

      • Kinase assays for phosphorylation

      • Glycosyltransferase assays for glycosylation

      • E3 ligase assays for ubiquitination

      • Detection of modified products with CYP71B34 antibodies

    4. Comparative PTM Analysis:

      • Treatment vs. control conditions

      • Developmental stages

      • Different tissues

      • Stress responses
        The plant antibody literature suggests that post-translational modifications can significantly affect antibody detection, with glycosylation being particularly important for secreted antibodies . This highlights the importance of considering PTMs when interpreting CYP71B34 antibody results.

  • What are the best strategies for designing transient expression experiments to study CYP71B34 function using antibodies?
    Transient expression systems offer powerful approaches to study CYP71B34 function:

    1. Agrobacterium-Mediated Transient Expression System:

      • Vector construction:

        • CaMV35S promoter for strong expression

        • C-terminal tags (GFP, HA, FLAG) for detection alternatives

        • Gateway-compatible vectors like pEarleyGate103 for fusion proteins

      • Agrobacterium preparation:

        • Use GV3101-pMP90 strain grown in LB with selective antibiotics

        • Resuspend in infiltration buffer (20 mM MES, 20 mM MgSO₄, 150 mg/L acetosyringone)

        • Adjust to OD₆₀₀ = 0.8-1.0

      • Infiltration technique:

        • 4-week-old Nicotiana benthamiana plants

        • Infiltrate 0.5 mL into abaxial leaf surface using needleless syringe

        • Include p19 silencing suppressor for enhanced expression

    2. Experimental Controls:

      • Empty vector control

      • Unrelated protein of similar size/localization

      • Wild-type CYP71B34 vs. mutated versions

      • Time-course analysis (typically days 1-7 post-infiltration)

    3. Analysis Approaches Using Antibodies:

      • Western blot time-course after infiltration

      • Co-immunoprecipitation for interaction studies

      • Immunolocalization in infiltrated tissue

      • Activity assays from infiltrated tissue extracts

    4. Functional Analysis Options:

      • Substrate conversion assays

      • Metabolite profiling (LC-MS)

      • Co-expression with pathway partners

      • Phenotypic assays relevant to hypothesized function
        This approach has been successfully employed for studying various plant proteins as demonstrated in research on lignin biosynthesis regulation, where protein function was analyzed through transient expression followed by RNA-Seq and targeted analysis .

Table 1: Comparative Analysis of Antibody Generation Methods for Plant Membrane Proteins

MethodSuccess Rate with Membrane ProteinsTime RequiredCostAdvantagesLimitations
Genetic Immunization70-80%8-12 weeks$$Preserves native protein structure, works with low-abundance proteinsRequires specialized delivery equipment, variable expression levels
Recombinant Protein40-60%16-20 weeks$$$Full-length protein as immunogen, controlled productionRequires optimization of expression and purification, potential folding issues
Synthetic Peptide30-50%12-16 weeks$$Targeted epitope design, consistent qualityMay not represent native protein structure, potential cross-reactivity
KLH-Conjugated Peptides40-60%12-16 weeks$$Enhanced immunogenicity, good for linear epitopesMay miss conformational epitopes, variable specificity

Table 2: CYP71B34 Detection Methods - Sensitivity Comparison

Detection MethodLower Limit of DetectionSample RequirementQuantitative?ThroughputTechnical Complexity
Western Blot~10-50 ngMicrosomal fractionSemiLow-MediumMedium
ELISA~0.1-1 ngTotal protein extractYesHighMedium
ImmunohistochemistryCell-level detectionFixed tissue sectionsSemiLowHigh
Flow CytometryCell-level detectionProtoplastsYesHighHigh
Mass Spectrometry~1-10 ngPurified/enriched samplesYesMediumVery High

Table 3: Research Findings on Antibody Specificity Controls for Plant Cytochrome P450s

Control TypeImplementationExpected OutcomeInterpretation
Genetic knockoutCRISPR/Cas9 or T-DNA insertion linesLoss of antibody signalHigh specificity
RNAi knockdownVirus-induced gene silencing (VIGS)Reduced antibody signalGood specificity
OverexpressionTransient expression in N. benthamianaEnhanced signal in expected locationConfirms detection capability
Peptide competitionPre-incubation with immunizing peptideBlocked antibody signalConfirms epitope specificity
Cross-species validationTest in related plant speciesSignal in expected tissues with size shiftsDemonstrates broad utility

Figure 1: Key Research Applications of CYP71B34 Antibodies in Plant Biology

  • Protein Expression Profiling

    • Western blot analysis across developmental stages

    • Tissue-specific expression mapping

    • Stress-responsive expression dynamics

  • Subcellular Localization Studies

    • Immunofluorescence microscopy

    • Immuno-electron microscopy

    • Subcellular fractionation validation

  • Protein-Protein Interaction Analysis

    • Co-immunoprecipitation

    • Proximity ligation assays

    • Pull-down validation

  • Post-Translational Modification Studies

    • Phosphorylation dynamics

    • Glycosylation patterns

    • Ubiquitination and turnover analysis

  • Enzyme Activity Correlation

    • Protein levels vs. enzyme activity

    • Inhibitor effects on protein stability

    • Structure-function relationships

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.